Barbui, Tiziano, Finazzi, Guido, Carobbio, Alessandra ORCID: 0000-0001-9664-7084, Thiele, Juergen, Passamonti, Francesco ORCID: 0000-0001-8068-5289, Rumi, Elisa ORCID: 0000-0002-7572-9504, Ruggeri, Marco, Rodeghiero, Francesco, Randi, Maria Luigia, Bertozzi, Irene, Gisslinger, Heinz, Buxhofer-Ausch, Veronika, De Stefano, Valerio ORCID: 0000-0002-5178-5827, Betti, Silvia, Rambaldi, Alessandro ORCID: 0000-0002-3739-7502, Vannucchi, Alessandro M. and Tefferi, Ayalew (2012). Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood, 120 (26). S. 5128 - 5134. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Full text not available from this repository.

Abstract

Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform for prospective studies exploring preventive measures. Current risk stratification for thrombosis in ET is 2-tiered and considers low-and high-risk categories based on the respective absence or presence of either age > 60 years or history of thrombosis. In an international study of 891 patients with World Health Organization (WHO)-defined ET, we identified additional independent risk factors including cardiovascular risk factors and JAK2V617F. Accordingly, we assigned risk scores based on multivariable analysis-derived hazard ratios (HRs) to age > 60 years (HR = 1.5; 1 point), thrombosis history (HR = 1.9; 2 points), cardiovascular risk factors (HR = 1.6; 1 point), and JAK2V617F (HR = 2.0; 2 points) and subsequently devised a 3-tiered prognostic model (low-risk = < 2 points; intermediate-risk = 2 points; and high-risk = > 2 points) using a training set of 535 patients and validated the results in the remaining cohort (n = 356; internal validation set) and in an external validation set (n = 329). Considering all 3 cohorts (n = 1220), the 3-tiered new prognostic model (low-risk n = 474 vs intermediate-risk n = 471 vs high-risk n = 275), with a respective thrombosis risk of 1.03% of patients/y versus 2.35% of patients/y versus 3.56% of patients/y, outperformed the 2-tiered (low-risk 0.95% of patients/y vs high-risk 2.86% of patients/y) conventional risk stratification in predicting future vascular events. (Blood. 2012; 120(26): 5128-5133)

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Barbui, TizianoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Finazzi, GuidoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Carobbio, AlessandraUNSPECIFIEDorcid.org/0000-0001-9664-7084UNSPECIFIED
Thiele, JuergenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Passamonti, FrancescoUNSPECIFIEDorcid.org/0000-0001-8068-5289UNSPECIFIED
Rumi, ElisaUNSPECIFIEDorcid.org/0000-0002-7572-9504UNSPECIFIED
Ruggeri, MarcoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rodeghiero, FrancescoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Randi, Maria LuigiaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bertozzi, IreneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gisslinger, HeinzUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Buxhofer-Ausch, VeronikaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
De Stefano, ValerioUNSPECIFIEDorcid.org/0000-0002-5178-5827UNSPECIFIED
Betti, SilviaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rambaldi, AlessandroUNSPECIFIEDorcid.org/0000-0002-3739-7502UNSPECIFIED
Vannucchi, Alessandro M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tefferi, AyalewUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-476538
DOI: 10.1182/blood-2012-07-444067
Journal or Publication Title: Blood
Volume: 120
Number: 26
Page Range: S. 5128 - 5134
Date: 2012
Publisher: AMER SOC HEMATOLOGY
Place of Publication: WASHINGTON
ISSN: 1528-0020
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; RISK STRATIFICATION; V617F MUTATION; LEUKOCYTOSIS; SURVIVAL; MANAGEMENT; ARTERIALMultiple languages
HematologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/47653

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item